The company utilizes unique technologies and engineering processes to rapidly manufacture cellular drugs with innovative disease-fighting properties. Founded in 2018 and headquartered in Babraham, Cambridge, Empyrean Therapeutics is focused on creating a platform that enables the development of next-generation cell therapies for widespread and cost-effective treatment of diseases.